More Than 82 Million Doses of COVID-19 Shots Discarded in U.S. Due to Low Demand
The U.S. Centers for Control and Disease Prevention (CDC) said that pharmacies, state health authorities and federal agencies in the United States discarded 82.1 million doses of COVID-19 shots between December 2020 and May 2022. The discarded doses equate to over 11 percent of the COVID vaccine doses the U.S. government distributed across the country.1 […]
Study Shows Sperm Concentration Decreased Three Months Following Pfizer’s COVID-19 Vaccinations
In a new study published in the journal Andrology, researchers found what they believe to be a temporary decline of sperm concentration and total motile count among sperm donors in Israel three months following vaccination with Pfizer/BioNTech’s BNT162b2 (also known as “Comirnaty”) messenger RNA (mRNA) COVID-19 biologic.1 Study Investigates the Effect of the Pfizer COVID […]
Claims for Injury, Death from COVID Shots Surge
Opinion | The Countermeasures Injury Compensation Program (CICP) is a program of the U.S. government that provide financial compensation for people who have suffered serious injuries or death from vaccines, biologics, antivirals or other drugs, as well medical devices used to “diagnose, prevent or treat a declared pandemic, epidemic or security threat.” The program was […]
FDA Panel Recommends EUA for Novavax COVID-19 Vaccine
Despite concerns about the risk of developing myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining of the heart) following vaccination with Novavax’s experimental NVX-CoV2373 (also known as “Nuvaxovid” and “Covovax”) COVID-19 vaccine, the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted on June 6, […]
Guillain-Barré Syndrome Linked to COVID-19 Shots
A study by the University College London showed that serious Guillain-Barré syndrome (GBS), which can result in temporary or permanent paralysis, is a “small but significant” risk associated with AstraZeneca/Oxford University’s AZD1222 (or “Vaxzevria”) vaccine. Of the 996 cases of GBS that were recorded in the United Kingdoms’ National Immunisation Management System database between January […]
Pfizer, Moderna Apply for EUA for COVID Shots for Infants, FDA to Decide Quickly
On June 1, 2022, Pfizer and BioNTech submitted an application to the U.S. Food and Drug Administration (FDA) for an Emergency Use Authorization (EUA) to distribute their messenger RNA (mRNA) BNT162b2 (also known as “Comirnaty”) COVID-19 biologic for children as young as six months to five years old. The application is for a three-dose regimen, […]